Purchase Order 75N93021P01057
- Not listed
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $12,110.90 firm fixed-price purchase order was for the supply of unspecified chemicals and is designated as a total small business set-aside. Genscript USA Inc. is a well-established provider of molecular biology products and services to federal...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $9,062.13 firm fixed-price purchase order is for plasmid and recombinant protein expression services to support NIAID's biomedical research and public health initiatives. Genscript, a for-profit organization, has a history of...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,833.25 contract is for custom gene synthesis services to support NIAID's biomedical research and public health initiatives. While the award does not have a set-aside designation, Genscript has previously received some small business...
- This federal contract award, valued at $10,420.74, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of custom gene synthesis services to support biomedical research and public health initiatives. Genscript USA Inc. is a prime contractor that has received numerous awards from HHS...
- This is a $8,073.05 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the synthesis of a specific gene, HHSN272201200153P. Genscript, which is not a small business set-aside, has received numerous previous contracts from HHS agencies like the National Institutes of Health, Centers for...
- This is a $10,594.44 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey, without a set-aside designation. The contract requires Genscript to provide a range of molecular biology products and services, including gene synthesis, gene...
- This federal contract award, valued at $4,263.55, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract is for the provision of various molecular biology products and services, including gene synthesis, gene editing, custom protein and antibody production, to support biomedical research and public health initiatives. While...
This $12,922.70 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The award is for the provision of various laboratory equipment and accessories, including thermostats, centrifuges, and rotors. While the contract has no set-aside designation, Genscript has received other awards from agencies like the U.S. Department of Agriculture (USDA) that have been set aside for small businesses. Genscript's specialized capabilities in gene synthesis, protein production, and related services have proven valuable for federal agencies supporting biomedical research and public health initiatives, including efforts to rapidly develop materials for emerging infectious disease threats.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 3/15/22 | |
| Not listed | Not listed | $12.9k | 7/29/21 |